Abionyx manufactures a new batch of ApoA-I CER-001
The vital second batch represents a critical step on the candidate’s pathway to regulatory approval
Read Moreby John Pinching | Jul 28, 2023 | News | 0
The vital second batch represents a critical step on the candidate’s pathway to regulatory approval
Read Moreby Lucy Parsons | Jun 10, 2021 | News | 0
Consortium will assess multiple process analytical technologies used in the cell and gene therapy industry
Read Moreby Selina McKee | Apr 7, 2021 | News | 0
The £20 million fund will boost the UK’s life sciences manufacturing capabilities, creating new economic opportunities and highly skilled jobs
Read Moreby Lucy Parsons | Feb 25, 2021 | News | 0
Production site in Måløv, Denmark manufactures products for oral diabetes treatment Rybelsus
Read Moreby Selina McKee | Jul 24, 2020 | News | 0
New state-of-the-art centre to scale up COVID-19 vaccine and gene therapy manufacturing gets £100 million investment
Read Moreby Selina McKee | May 22, 2020 | News | 0
Samsung will provide GSK with additional flexible capacity for large-scale biopharmaceutical product manufacturing
Read Moreby Anna Smith | Dec 6, 2019 | News | 0
The online retail giant’s honed data abilities will help Novartis produce more personalised therapies.
Read Moreby Selina McKee | Nov 25, 2018 | News | 0
The Cell and Gene Therapy (CGT) Catapult has launched the first Advanced Therapy Medicinal Products (ATMP) focused apprenticeship programme, developed in partnership with The Medicine Manufacturing Industry Partnership (MMIP).
Read Moreby Selina McKee | Nov 25, 2018 | News | 0
UK gene and cell therapy group Oxford BioMedica has announced a new digital framework initiative to streamline the production of next-generation medicines.
Read Moreby Selina McKee | Nov 22, 2018 | News | 0
The UK’s cell and gene therapy industry has seen a 60% increase in manufacturing space in the last year, new research published by the Cell and Gene Therapy (CGT) Catapult has revealed.
Read Moreby Selina McKee | Oct 3, 2018 | News | 0
Medherant has been awarded a grant by Innovate UK to help it upscale production of its TEPI Patch drug delivery system for clinical trials.
Read Moreby Selina McKee | Sep 25, 2018 | News | 0
Novartis has announced plans to close its manufacturing site in Grimsby, UK, by the end of 2020, among a wider job cull likely to affect more than 2,200 positions in the country and Switzerland.
Read More





PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
